Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

December 14, 2015

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions
Esophageal Cancer
Interventions
DRUG

Nivolumab

DRUG

Docetaxel/Paclitaxel

Trial Locations (89)

333

Taoyuan Clinical Site, Taoyuan District

500

Changhua Clinical Site, Changhua

704

Tainan Clinical Site, Tainan City

807

Kaohsiung Clinical Site, Kaohsiung City

5000

Odense University Hospital, Odense C

10048

Taipei Clinical Site, Taipei

11217

Taipei Clinical Site, Taipei

13620

Gyeonggi-do Clinical Site, Gyeonggi-do

20007

Georgetown University Med Ctr, Washington D.C.

20133

Fondazione Irccs Istituto Nazionale Tumori, Milan

20445

Keelung Clinical Site, Keelung

24127

HPG23, Bergamo

27710

Duke Cancer Institute, Durham

32806

Orlando Health, Inc, Orlando

35015

Daejeon Clinical Site, Daejeon

35128

Irccs Istituto Oncologico Veneto Iov, Padua

37232

Vanderbilt-Ingram Cancer Ctr, Nashville

40447

Taichung Clinical Site, Taichung

41404

Daegu Clinical Site, Daegu

41931

Daegu Clinical Site, Daegu

44033

Ulsan Clinical Site, Ulsan

49241

Busan Clinical Site, Busan

52057

RWTH Aachen University, Aachen

55131

University Of Mainz Medical Center, Mainz

58128

Hwasun-Gun Clinical Site, Hwasun-Gun

61363

Chiayi Clinical Site, Chiayi City

69120

University Hospital Heidelberg, Heidelberg

77030

The University Of Texas MD Anderson Cancer Center, Houston

81675

Klinikum reechts der Isar, Technical University Munchen, Munich

82445

Kaohsiung Clinical Site, Kaohsiung City

83301

Kaohsiung Clinical Site, Kaohsiung City

85234

Banner MD Anderson Cancer Center, Gilbert

02114

Massachusetts General Hospital, Boston

D-13353

Charite Campus Virchow Klinikum, Berlin

07747

Universitatsklinikum Jena, Innere Medizin II, Jena

04103

MVZ Mitte, Leipzig

464-8681

Aichi Clinical Site, Nagoya

466-8560

Aichi Clinical Site, Nagoya

036-8563

Aomori Clinical Site, Hirosaki

277-8577

Chiba Clinical Site, Kashiwa

791-0288

Ehime Clinical Site, Matsuyama

003-0027

Hokkaido Clinical Site, Sapporo

060-8648

Hokkaido Clinical Site, Sapporo

673-0021

Hyogo Clinical Site, Akashi

650-0047

Hyogo Clinical Site, Kobe

259-1193

Kanagawa Clinical Site, Isehara

216-0015

Kanagawa Clinical Site, Kawasaki

236-0004

Kanagawa Clinical Site, Yokohama

241-8515

Kanagawa Clinical Site, Yokohama

514-8507

Mie Clinical Site, Tsu

980-8574

Miyagi Clinical Site, Sendai

385-0051

Nagano Clinical Site, Saku

951-8520

Niigata Clinical Site, Nigatake

589-8511

Osaka Clinical Site, Sayama

565-0871

Osaka Clinical Site, Suita

569-0801

Osaka Clinical Site, Takatsuki

350-1298

Saitama Clinical Site, Hidaka

362-0806

Saitama Clinical Site, Kita-Adachi County

411-8777

Shizuoka Clinical Site, Suntou County

329-0431

Tochigi Clinical Site, Shimotsuke

113-0021

Tokyo Clinical Site, Bunkyo-ku

104-0045

Tokyo Clinical Site, Chuo-ku

104-8560

Tokyo Clinical Site, Chuo-ku

135-8550

Tokyo Clinical Site, Koto-ku

152-8902

Tokyo Clinical Site, Meguro-ku

105-8470

Tokyo Clinical Site, Minato-ku

142-8666

Tokyo Clinical Site, Shinagawa-ku

160-8582

Tokyo Clinical Site, Shinjuku-ku

162-8666

Tokyo Clinical Site, Shinjuku-ku

010-8543

Akita Clinical Site, Akita

260-0801

Chiba Clinical Site, Chiba

260-8677

Chiba Clinical Site, Chiba

812-8582

Fukuoka Clinical Site, Fukuoka

960-1295

Fukushima Clinical Site, Fukushima

734-8551

Hiroshima Clinical Site, Hiroshima

890-8520

Kagoshima Clinical Site, Kagoshima

860-8556

Kumamoto Clinical Site, Kumamoto

602-8566

Kyoto Clinical Site, Kyoto

606-8507

Kyoto Clinical Site, Kyoto

951-8566

Niigata Clinical Site, Niigata

537-8511

Osaka Clinical Site, Osaka

420-8527

Shizuoka Clinical Site, Shizuoka

03080

Seoul Clinical Site, Seoul

03722

Seoul Clinical Site, Seoul

05505

Seoul Clinical Site, Seoul

06351

Seoul Clinical Site, Seoul

06591

Seoul Clinical Site, Seoul

CF142TL

Velindre Cancer Centre, Cardiff

G12 0YN

The Beatson West Of Scotland Cancer Centre, Glasgow

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Ono Pharmaceutical Co. Ltd

INDUSTRY